Stocks
Boston Scientific (BSX) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 5.17 | 2.99 | 3.05 | 2.38 | 2.50 | 2.34 | |||
| Changes by years, y/y, % | +13% | -42% | +2% | -22% | +5% | -2.6% | |||
Boston Scientific. Debt/EBITDA
Boston Scientific. Debt/EBITDA, changes, %
Boston Scientific (BSX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 2.57 | 2.54 | 2.38 | 2.17 | 2.34 | 2.34 | ||
| Changes by years, y/y, % | +6% | +4% | -22% | -28% | -7% | |||
| Changes by quarters, q/q, % | +2% | -1% | -6% | -9% | +8% | |||
